Loading data
CALCNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 15.23 m USD | 14.48 m USD | 15.86 m USD | 8.35 m USD | 18.9 m USD |
| Operating profit | -23.12 m USD | -24.2 m USD | -38.08 m USD | -14.19 m USD | -35.95 m USD |
| Profit before tax | -29.56 m USD | -13.7 m USD | — | — | — |
| Income tax expense | 0 USD | 0 USD | 1 k USD | 1 k USD | — |
| Net income (reported basis) | -29.56 m USD | -13.7 m USD | -34.36 m USD | -7.82 m USD | -35.82 m USD |
| Net income attributable to common shareholders | -29.56 m USD | -13.7 m USD | -34.36 m USD | -9.14 m USD | — |
| Basic earnings per share | -1.97 USD/share | -1.22 USD/share | -7.66 USD/share | -111.16 USD/share | -1.69 USD/share |
| Diluted earnings per share | -1.97 USD/share | -1.22 USD/share | -7.66 USD/share | -111.16 USD/share | -1.69 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.